Regulatory approval to Cadila Healthcare's Zydus for human trials of a potential #COVID19 vaccine too boosted domestic investor sentiment, traders said.

#ZydusCadila #vaccine #StockMarket #stocks #Sensex #Nifty 
https://t.co/PR4fho7xzi